Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Kansas City Southern (KSU) downgraded to Peer Perform from Outperform at Wolfe Research with analyst Scott Group saying the implied takeout price for KCS is now $287 based on CP's current share price. 2. Evergy (EVRG) downgraded to Neutral from Buy at BofA with analyst Julien Dumoulin-Smith saying following 10% outperformance versus peers year-to-date, Evergy shares are now trading at a premium to electric peers, showing limited upside to the valuation and estimates. 3. Integra LifeSciences (IART) downgraded to Neutral from Buy at BTIG with analyst Ryan Zimmerman seeing limited share upside in the near to mid-term stemming from limited intensive care unit bed capacity for elective neurosurgery, a CEO transition that "creates the potential for disruption" and limited margin expansion due to labor shortages and raw material increases. 4. Itamar Medical (ITMR) downgraded to Neutral from Buy at Ladenburg with analyst Jeffrey Cohen citing a definitive acquisition agreement whereby ZOLL Medical will acquire all outstanding ordinary shares of Itamar at an estimated value of $538M. 5. Chevron (CVX) downgraded to Neutral from Overweight with Southwestern Energy (SWN) downgraded to Underweight from Neutral at JPMorgan. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.